Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

HIV-2 and T cell recognition

H C Whittle1, K Ariyoshi, S Rowland-Jones

  • 1MRC Laboratories, The Gambia, West Africa. whittle@commit.gm

Current Opinion in Immunology
|September 2, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of comorbidities on quality of life in Filipino people with tuberculosis.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2020
Same author

Accuracy of composite diagnostic standards for pneumococcal pneumonia in vaccine trials.

Epidemiology and infection·2018
Same author

Bacterial co-infection and early mortality among pulmonary tuberculosis patients in Manila, The Philippines.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2018
Same author

A35 Viral evolution and innate immune responses during acute HIV-1 infection and their association with disease pathogenesis.

Virus evolution·2017
Same author

Campaigns with oral polio vaccine may lower mortality and create unexpected results.

Vaccine·2017
Same author

HLA-C*16:01:01:02, a recently isolated HLA class I allele from Southern Africa.

HLA·2016
Same journal

A blind spot of human T cell immunology: epitope specificity in secondary lymphoid organs.

Current opinion in immunology·2026
Same journal

Germinal center responses at barrier organ sites.

Current opinion in immunology·2026
Same journal

Ocular sarcoidosis: from clinical signs to targeted interventions.

Current opinion in immunology·2026
Same journal

On or within: spatial determinants of antigen handling in the nasal turbinates.

Current opinion in immunology·2026
Same journal

Decoding the complexity of intestinal immunity with spatial transcriptomics.

Current opinion in immunology·2026
Same journal

Reconsidering the immunological aspects of solid-phase assays for antiphospholipid antibodies detection.

Current opinion in immunology·2026
See all related articles

Human Immunodeficiency Virus type 2 (HIV-2) shows lower pathogenicity and transmissibility than HIV-1. Research suggests more efficient T cell recognition and viral replication control in HIV-2, offering insights for vaccine development.

Area of Science:

  • Virology
  • Immunology
  • Vaccine Development

Background:

  • Human Immunodeficiency Virus type 2 (HIV-2) is known to be less pathogenic and transmissible compared to Human Immunodeficiency Virus type 1 (HIV-1).
  • Understanding the mechanisms behind HIV-2's reduced virulence is critical for advancing HIV/AIDS research and therapeutic strategies.

Purpose of the Study:

  • To explore the potential for more efficient T cell recognition and viral replication control in HIV-2 infections.
  • To investigate the role of deletions in the HIV nef gene and immune cross-reactions in the context of HIV-2, HIV-1, and Simian Immunodeficiency Virus (SIV) infections.
  • To leverage these findings for the design of more effective vaccines against HIV.

Main Methods:

  • Analysis of deletions within the HIV nef gene.

Related Experiment Videos

  • Examination of immune cross-reactions between HIV-2, HIV-1, and SIV.
  • Comparative assessment of T cell recognition and viral replication control.

    • Main Results:

    • Evidence suggests that T cell recognition may be more efficient in HIV-2 infected individuals.
    • The control of viral replication appears to be more effective during HIV-2 infection compared to HIV-1.
    • Specific genetic factors, like nef gene deletions, and cross-immune responses contribute to these differences.

    Conclusions:

    • HIV-2's distinct characteristics, including enhanced T cell responses and replication control, offer valuable insights.
    • These findings are crucial for informing the development of novel and effective vaccines targeting HIV.
    • Further research into HIV-2 pathogenesis can guide strategies to combat HIV-1 and related viruses.